The Institute for Clinical and Economic Review (ICER) analysis (2025) reaffirmed that even after price drops, GLP-1s consume a large share of pharmacy budgets, though at cost-effective levels relative to benefit ( [11] )
Monolaurin from coconut oil can be very effective treatment for both HSV and EBV
SGLT2is have the benefit of being oral agents, which may make them an attractive choice for prescribers and a convenient add-on treatment for patients [11]
Considering the totality of evidence from clinical trials, post-marketing reports and observational studies, alongside the generally low incidence rate of NAION, Novo Nordisk believes that the benefit-risk profile of semaglutide remains favorable, the spokesperson said.
Semaglutide is intended for the management of type 2 diabetes and weight management
When protein reaches intestinal L-cells, it triggers significantly more GLP-1 release than carbohydrates or fat